The molecular basis of vascular disorders

American Journal of Human Genetics

Volumn 64, Issue 3, 1999, Pages 678-684

  Towbin, Jeffrey A ^a,b   Casey, Brett ^a   Belmont, John ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALAGILLE SYNDROME; ANGIOGENESIS; AORTA ANOMALY; AORTA COARCTATION; AORTA STENOSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MALFORMATION; CONGENITAL HEART MALFORMATION; DEVELOPMENT; EHLERS DANLOS SYNDROME; GENE MUTATION; HYPOPLASTIC LEFT HEART SYNDROME; MARFAN SYNDROME; PRIORITY JOURNAL; PULMONARY ARTERY MALFORMATION; REVIEW; WILLIAMS BEUREN SYNDROME;

EID: 0033358143     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302303     Document Type: Article

References (31)

1. Andrikopoulos K, Liu X, Keene DR, Jaenisch R, Ramirez F (1995) Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet 9:31-36
2. Belmont JW (1998) Recent progress in the molecular genetics of congenital heart defects. Clin Genet 54:11-19
3. Casey B (1998) Two rights make a wrong: human left-right malformations. Hum Mol Genet 7:1565-1571
4. Clark EB (1986) Mechanisms in the pathogenesis of congenital cardiac malformations. In: Pierpont ME, Moller JH (eds) Genetics of cardiovascular disease. Martinus Nijhoff, Hingham, MA
5. Cleaver O, Krieg PA (1998) Molecular mechanisms of vascular development. In: Harvey RP, Rosenthal N (eds) Heart development. Academic Press, San Diego, pp 221-252
6. De Paepe A, Nuytinck L, Hausser I, Anton-Lamprecht I, Nauyaert J-M (1997) Mutations in the COL5AI gene are causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet 60:547-554
7. Ferencz C, Loffredo CA, Correa-Villaseñor A, Wilson P (1997) Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington Infant Study 1981-1989. Futura, Armonk, NY
8. Fishman MC, Chien KR (1997) Fashioning the vertebrate heart; earliest embryonic decisions. Development 124: 2099-2117
9. Funke B, Puech A, Saint-Jore B, Pandita R, Skoultchi A, Morrow B (1998) Isolation and characterization of a human gene containing a nuclear localization signal from the critical region for velo-cardio-facial syndrome on 22q11. Genomics 53:146-154
10. Giddins NG, Finley JP, Nanton MA, Roy DL (1989) The natural course of supravalvular aortic stenosis and peripheral pulmonary artery stenosis in Williams syndrome. Br Heart J 62:315-319
11. Gottlieb S, Driscoll DA, Punnett HH, Sellinger B, Emanuel BS, Budarf ML (1998) Characterization of 10p deletions suggests two nonoverlapping regions contribute to the DiGeorge Syndrome phenotype. Am J Hum Genet 62:495-498
12. Ho SY, Anderson RH (1979) Coarctation, tubular hypoplasia, and the ductus arteriosus. Histological study of 35 specimens. Br Heart J 41:268-274
13. Kosaki R, Gebbia M, Kosaki K, Lewin M, Bowers P, Towbin JA, Casey B (1999) Left-right axis malformations associated with nucleotide substitutions in ACVR2B, the gene for human activin receptor type HB. Am J Med Genet 82:70-76
14. Krantz ID, Piccoli DA, Spinner NB (1997) Alagille syndrome. J Med Genet 34:152-157
15. Levin M (1997) Left-right asymmetry in vertebrate embryo-genesis. BioEssays 19:287-296
16. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, et al (1997) Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16:243-251
17. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP (1995) Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeobox gene Nkx2-5. Genes Dev 9:1654-1666
18. Marchuk DA (1998) Genetic abnormalities in hereditary hemorrhagic telangiectasia. Curr Opin Hematol 5:332-338
19. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, et al (1994) Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8: 345-351
20. Michalickova K, Susic M, Willing MC, Wenstrup RJ, Cole WG (1998) Mutations of the α2(V) chain of type V collagen impair matrix assembly and produce Ehlers-Danlos syndrome type 1. Hum Mol Genet 7:249-255
21. Milewicz DM (1998) Molecular genetics of Marfan syndrome and Ehlers-Danlos type IV. Curr Opin Cardiol 13:198-204
22. Morris CA (1998) Genetic aspects of supravalvular aortic stenosis. Curr Opin Cardiol 13:214-219
23. O'Connor WN, Davis JB, Geissler R, Cottrill CM, Noonan JA, Todd EP (1985) Supravalvular aortic stenosis. Clinical and pathological observations in six patients. Arch Pathol Lab Med 109:179-185
24. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli DA, et al (1997) Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16: 235-242
25. Ring CJ, Cho KWY (1999) Specificity in transforming growth factor-β signaling pathways. Am J Hum Genet 64:691-697 (in this issue)
26. Scambler PJ (1993) A genetic etiology for DiGeorge syndrome, velo-cardio-facial syndrome and familial congenital heart defect. In: Yacoub IM, Pepper J (eds) Annual of cardiac surgery, Current Science, London
27. Schmidt MA, Ensing GJ, Michels W, Carter GA, Hagler DJ, Feldt RH (1989) Autosomal dominant supravalvular aortic stenosis: large three generation family. Am J Med Genet 32: 384-389
28. Towbin JA, McQuinn TC (1995) gridlock: a model for coarctation of the aorta? Nat Med 1:1141-1142
29. Vikkula M, Boon LM, Carraway KL, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, et al (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190
30. Walsh K, Perlman HR, Smith RC (1998) Regulation of vascular smooth muscle differentiation and cell cycle. In: Harvey RP, Rosenthal N (eds) Heart development. Academic Press, San Diego, pp 429-443
31. Weinstein BM, Stemple DL, Driever W, Fishman MC (1995) gridlock, a localized heritable vascular patterning defect in the zebrafish. Nat Med 1:1143-1147